UNIT 22F.11 Differentiation and Characterization of Dendritic Cells from Human Embryonic Stem Cells

  1. Kanishka Mohib1,
  2. Lisheng Wang1,2,3

Published Online: 1 AUG 2012

DOI: 10.1002/0471142735.im22f11s98

Current Protocols in Immunology

Current Protocols in Immunology

How to Cite

Mohib, K. and Wang, L. 2012. Differentiation and Characterization of Dendritic Cells from Human Embryonic Stem Cells. Current Protocols in Immunology. 98:F:22F.11:22F.11.1–22F.11.22.

Author Information

  1. 1

    Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada

  2. 2

    Regenerative Medicine Program, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada

  3. 3

    Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Ontario, Canada

Publication History

  1. Published Online: 1 AUG 2012
  2. Published Print: AUG 2012


Human embryonic stem cells (hESCs) offer great hope in regenerative medicine. Their ability to give rise to almost any type of cell present in the adult body makes them an invaluable tool in finding cures for a variety of diseases. While considerable protocols have been devised to efficiently differentiate hESCs into various cells types including cells of hematopoietic origin, this protocol will focus on the derivation of dendritic cells (DC), a potent antigen-presenting cell. DCs are a highly important arm of the immune system, as they represent one of the few cells that bridge the innate and adaptive systems, leading to effective pathogen clearance. The study of DCs has led to potential applications in diverse fields, such as vaccine development, tumor immunology, and transplantation. In this protocol, we describe two different methods of differentiating hESCs into DCs. The first method uses OP9 bone marrow stromal supporting cells as a coculture system, while the second method utilizes the formation of embryoid body (EB, cellular aggregate) as an approach. To assure the successful outcome and subsequent assessment of the differentiated DCs, supporting protocols have been included in this chapter. Curr. Protoc. Immunol. 98:22F.11.1-22F.11.22. © 2012 by John Wiley & Sons, Inc.


  • Human embryonic stem cells;
  • hematopoietic progenitor cells;
  • dendritic cells